Strategy
Evidence strategy & planning
Define the decision the evidence must support, the audience that has to accept it and the study design that gets you there.
●Healthcare consulting · Real-world evidence & health data
Real-world evidence that payers, regulators and partners trust.
At Ladder Insights, we help life sciences teams, health data companies, investors and research institutions turn real-world data into evidence that holds up with the people who decide: payers, regulators, health systems and research partners.
01What we do
Evidence strategy, from the first question to a trusted result.
Real-world evidence (RWE) is only as useful as the decision it supports. We start there, then work back to the data, partners and plan that will get you an answer people accept.
Data
Data source assessment
Evaluate claims, electronic health record, registry and other real-world data sources for coverage, fit, cost and licensing terms before you commit.
Licensing
Data licensing & commercialization
Licensing models, pricing and programs for health data companies, including academic and research licensing.
Research
Research & grant partnerships
Support for academic institutions and research partners building real-world data into funded research proposals.
Access
Payer & HTA evidence needs
What payers, purchasers and health technology assessment (HTA) agencies need to see, and how to build it into your plan early.
Collaboration
Quality measures & multi-party studies
Bringing competitors, purchasers and researchers together behind shared measures and studies that every party can defend.
02Who we work with
Built from inside the health data market.
Clients
Pharmaceutical & life sciencesHealth data & health IT companiesAcademic & research institutionsPayersFounders & investorsHealth systems
Our experience
- Leadership in real-world evidence at a national health data company, including building its academic licensing program
- Led support for academic institutions' NIH Alzheimer's disease and related dementias (AD/ADRD) real-world data proposals in 2023
- Aligned four life sciences companies behind one quality measure
- More than $300 million in multi-organization collaborations orchestrated
03How we work
Every engagement ends with a plan a busy executive can act on.
Diagnose
Name the decision, the audience and the standard of proof they will apply.
Map
Assess data sources, partners, gaps and cost against that standard.
Plan
Deliver an evidence plan with partners, budget, timeline and risks.
Execute
Support partner selection, contracts and delivery through first results.
04Common questions
What is real-world evidence?
Real-world evidence is clinical evidence about how a treatment, device or program performs in everyday care. It comes from analyzing real-world data such as insurance claims, electronic health records, registries and patient-reported information, rather than from a controlled clinical trial alone.
Who do you work with on real-world evidence?
Life sciences teams, health data and health IT companies, academic and research institutions, payers and the investors evaluating companies in this market.
Do you run the analytics yourselves?
Our focus is the strategy: what evidence is needed, which data can produce it and which partners to trust. If a project needs a dedicated analytics team, we tell you upfront and help you choose the right one.
How does an engagement start?
With a free 15-minute discovery call. If there is a fit, we send a written scope, timeline and fee before any work begins.
05Related services
More from our healthcare practice.
01New engagement
Book a discovery call.
A focused 15-minute conversation about what's stuck, what's been tried and what's at stake. You'll leave with a candid read on whether we're the right fit.
02Prefer email or phone?
Reach us directly.
Send a short note about your organization and what you're working on, and we'll follow up to find a time.
03Events & boards
Bring us to your stage.
Keynotes, panels, executive workshops and board briefings on healthcare markets, evidence and AI.